Cristián A. Amador, Paola Krall, Elizabeth Galdames, Jorge Morales & Karina Pino-Lagos — Frontiers in Medicine, 2026
This perspective article examines the current state of solid organ transplantation in Chile, with particular emphasis on the relationship between transplantation activity and the development of basic and clinical research. Chile now performs more than 600 transplants per year, while approximately 2,000 people remain on the waiting list, highlighting both the progress achieved and the continuing need for advances in transplantation medicine.
Over the 2015–2024 period, Chile recorded 1,572 effective donors and 6,040 transplants. Most organs came from deceased donors, and kidney and liver transplantation showed substantial growth. However, transplantation infrastructure remains highly centralized: 17 of the country’s 24 transplant units are located in Santiago’s Metropolitan Region, while the northern and austral macro-zones have no transplantation centers. The map presented in Figure 1 clearly illustrates this geographic imbalance.
Despite considerable clinical transplantation activity, the authors identify an important gap in basic transplantation research. Among 201 studies presented at relevant Chilean scientific meetings between 2015 and 2025, only 8% involved basic research, conducted by just two academic laboratories in Santiago. More than 90% focused instead on areas such as clinical reports, patient follow-up, surgical techniques, legal issues and experiences from individual transplantation centers.
Scientific publication in the field shows a similar pattern. A search covering the previous decade identified 120 publications related to organ transplantation, largely case reports and reviews, but only eight papers specifically related to transplantation tolerance, most involving basic research. The authors argue that this limited research base restricts Chile’s ability to contribute to scientific advances in transplantation despite its established clinical activity.
Looking forward, the article identifies research funding, geographic centralization and limited scientific infrastructure as major challenges. The authors call for stronger biobanks and data platforms, more trained personnel, greater use of national registries, advances in personalized medicine and closer collaboration among government, universities, healthcare institutions and scientific societies.